Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Abbisko Therapeutics

Abbisko Therapeutics

Abbisko Therapeutics is an immunomodulators for cancer founded in 2016.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Biomedical engineering

Location

Xinwu District, Taoyuan

0

0

0

Pitchbook URL

pitchbook.com/profiles...170363-35

Full Address

Floor 12B, Building 1, Lane 515, Huanke Road Pudong New Area Shanghai, 201203 China0

Place of Incorporation

Investors

Jianxin Capital

0

Temasek Holdings

0

Sinopharm Group

0

Lilly Asia Ventures

0

TF Capital (Shanghai)

0

Loyal Valley Capital

0

0

QiMing Venture Partners

0

Founded Date

2016

Stock Symbol

2256.HK

Exchange

Hong Kong Stock Exchange

Patents Assigned (Count)

1

Country

0

Headquarters

0

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Abbisko Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool